Dr. Misbah U. Qadir
Claim this profileVidant Oncology-Kinston
Expert in Cancer
Studies Lung Cancer
37 reported clinical trials
71 drugs studied
About Misbah U. Qadir
Education:
- Graduated from King Edward Medical University, Pakistan.
- Completed Residency in Internal Medicine at East Carolina University Brody School of Medicine, Greenville, NC.
- Undertook a Fellowship in Hematology/Oncology at East Carolina University Brody School of Medicine, Greenville, NC.
Experience:
- Currently affiliated with Vidant Oncology - Kinston.
Area of expertise
1Cancer
Global LeaderStage IV
Stage III
HER2 positive
2Lung Cancer
Stage IV
Stage III
Stage I
Affiliated Hospitals
Clinical Trials Misbah U. Qadir is currently running
Osimertinib + Bevacizumab
for Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Monoclonal antibodies, such as bevacizumab, may interfere with the ability of tumor cells to grow and spread. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting2 awards Phase 331 criteria
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
More about Misbah U. Qadir
Clinical Trial Related5 years of experience running clinical trials · Led 37 trials as a Principal Investigator · 16 Active Clinical TrialsTreatments Misbah U. Qadir has experience with
- Nivolumab
- Atezolizumab
- Fluorouracil
- Ipilimumab
- Cisplatin
- Carboplatin
Breakdown of trials Misbah U. Qadir has run
Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Misbah U. Qadir specialize in?
Misbah U. Qadir focuses on Cancer and Lung Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Misbah U. Qadir currently recruiting for clinical trials?
Yes, Misbah U. Qadir is currently recruiting for 15 clinical trials in Kinston North Carolina. If you're interested in participating, you should apply.
Are there any treatments that Misbah U. Qadir has studied deeply?
Yes, Misbah U. Qadir has studied treatments such as Nivolumab, Atezolizumab, Fluorouracil.
What is the best way to schedule an appointment with Misbah U. Qadir?
Apply for one of the trials that Misbah U. Qadir is conducting.
What is the office address of Misbah U. Qadir?
The office of Misbah U. Qadir is located at: Vidant Oncology-Kinston, Kinston, North Carolina 28501 United States. This is the address for their practice at the Vidant Oncology-Kinston.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.